JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on January 24, 2008; DOI: 10.1124/jpet.107.134296


0022-3565/08/3251-319-330$20.00
JPET 325:319-330, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.107.134296v1
325/1/319    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Lane, J. R.
Right arrow Articles by Milligan, G.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lane, J. R.
Right arrow Articles by Milligan, G.

CELLULAR AND MOLECULAR

G Protein Coupling and Ligand Selectivity of the D2L and D3 Dopamine Receptors

J. Robert Lane, Ben Powney, Alan Wise, Stephen Rees, and Graeme Milligan

Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow, United Kingdom (J.R.L., G.M.); and Screening and Compound Profiling, GlaxoSmithKline Research and Development, New Frontiers Science Park, Harlow, Essex, United Kingdom (B.P., A.W., S.R.)

The human dopamine D2L receptor couples promiscuously to multiple members of the G{alpha}i/o subfamily. Despite the high homology of the D2L and D3 receptors, the G protein coupling specificity of the human D3 receptor is less clearly characterized. The primary aim of this study, then, was the parallel characterization of the G protein coupling specificity of the D2L and D3 receptors. By using both receptor-G protein fusion proteins and stable cell lines in which pertussis toxin-resistant mutants of individual G{alpha}i-family G proteins were expressed in an inducible fashion, we demonstrated highly selective coupling of the D3 receptor to G{alpha}o1. Furthermore, by using the fusion proteins to ensure identical stoichiometry of receptor to G protein for each pairing, a range of ligands displayed higher potency and, for partial agonists, higher efficacy at the D3 receptor when coupled to G{alpha}o1 compared with the D2L receptor. The second aim of this study was to investigate the molecular basis of the above differential G protein coupling specificity. The importance of a 12-amino acid sequence from the C-terminal end of the third intracellular loop of the D2L receptor in providing promiscuity in G protein coupling was demonstrated using a chimeric D3/D2 receptor in which the equivalent region of the D3 receptor was exchanged for this sequence. This chimera displayed D3-like affinity for [3H]spiperone and potency for agonists but gained D2-like ability to couple to each of G{alpha}i1–3 as well as G{alpha}o1.


Received November 14, 2007; accepted January 23, 2008.

Address correspondence to: Dr. Graeme Milligan, Davidson Building, University of Glasgow, Glasgow G12 8QQ, Scotland, UK. E-mail: g.milligan{at}bio.gla.ac.uk







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics.